Skip to main content
. 2021 Aug 17;65(9):e00462-21. doi: 10.1128/AAC.00462-21

TABLE 2.

Comparison of other prescribed antibiotics and nephrotoxins between patients receiving concomitant vancomycin and melatonin and those receiving vancomycin alone

Antibiotic(s) No., %, of patients in:
P value
Control group (n = 202) Melatonin group (n = 101)
Cephalosporins 104, 51.5 57, 56.4 0.416
 Cefazolin 24, 11.9 23, 22.7 0.014
 Cefepime 40, 19.8 18, 17.8 0.680
 Cefoxitin 0, 0 2, 2.0 0.110
 Cefpodoxime 3, 1.5 2, 2.0 1.000
 Ceftriaxone 60, 29.7 31, 30.7 0.859
 Cephalexin 4, 2.0 3, 3.0 0.690
Penicillins 109, 54.0 55, 54.5 0.935
 Ampicillin-sulbactam 12, 5.9 7, 6.9 0.738
 Amoxicillin-clavulanic acid 3, 1.5 4, 4.0 0.227
 Oxacillin 2, 1.0 3, 3.0 0.338
 Piperacillin-tazobactam 100, 49.5 47, 46.5 0.626
Aminoglycosides 5, 2.5 1, 1.0 0.667
 Amikacin 0, 0.0 1, 1.0 0.333
 Gentamicin 5, 2.5 0, 0 0.173
Fluoroquinolones 20, 9.9 9, 8.9 0.782
 Ciprofloxacin 7, 3.5 1, 1.0 0.277
 Levofloxacin 13, 6.4 9, 8.9 0.434
Tetracyclines 10, 5.0 7, 6.9 0.480
 Doxycycline 10, 5.0 7, 6.9 0.480
Carbapenems 27, 13.4 18, 18.2 0.304
 Aztreonam 3, 1.5 1, 1.0 0.627
 Ertapenem 11, 5.4 3, 3.0 0.399
 Imipenem 1, 0.1 0, 0 1.000
 Meropenem 11, 5.4 14, 13.9 0.015
 Macrolides 32, 16.2 12, 12.1 0.356
 Azithromycin 24, 12.0 10, 10.1 0.607
Lincosamides 8, 4.0 2, 2.0 0.505
 Clindamycin 8, 4.0 2, 2.0 0.505
Other 49, 24.3 25, 25.3 0.925
 Trimethoprim-sulfamethoxazole 7, 3.5 5, 5.1 0.532
 Daptomycin 10, 5.0 4, 4.0 0.781
 Linezolid 5, 2.5 1, 1.0 0.667
 Metronidazole 33, 16.3 15, 15.2 0.739
 Nitrofurantoin 1, 0.1 2, 2.0 0.259
Other nephrotoxinsa 148, 73.3 79, 78.2 0.349
 NSAIDs 99, 49.0 47, 46.5 0.684
 ACEI/ARB 51, 25.2 29, 28.7 0.519
 Loop diuretics 69, 34.1 46, 45.5 0.054
 Contrast media 87, 43.1 36, 35.6 0.264
a

NSAIDs, nonsteroidal anti-inflammatory drugs; ACEI, angiotensin-converting enzyme inhibitors; ARB, angiotensin receptor blockers.